AT379594B - Verfahren zur herstellung von neuen 2,3,3a,4,5,6hexahydro-1h-indolo(3,2,1-de)-(1,5-naphtyridin) -derivaten und ihre pharmazeutisch zulaessigen saeureadditionssalze - Google Patents

Verfahren zur herstellung von neuen 2,3,3a,4,5,6hexahydro-1h-indolo(3,2,1-de)-(1,5-naphtyridin) -derivaten und ihre pharmazeutisch zulaessigen saeureadditionssalze

Info

Publication number
AT379594B
AT379594B AT0501381A AT501381A AT379594B AT 379594 B AT379594 B AT 379594B AT 0501381 A AT0501381 A AT 0501381A AT 501381 A AT501381 A AT 501381A AT 379594 B AT379594 B AT 379594B
Authority
AT
Austria
Prior art keywords
6hexahydro
naphtyridine
indolo
derivatives
acid addition
Prior art date
Application number
AT0501381A
Other languages
German (de)
English (en)
Other versions
ATA501381A (de
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ATA501381A publication Critical patent/ATA501381A/de
Application granted granted Critical
Publication of AT379594B publication Critical patent/AT379594B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • X-Ray Techniques (AREA)
  • Electrolytic Production Of Metals (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Secondary Cells (AREA)
AT0501381A 1980-11-21 1981-11-20 Verfahren zur herstellung von neuen 2,3,3a,4,5,6hexahydro-1h-indolo(3,2,1-de)-(1,5-naphtyridin) -derivaten und ihre pharmazeutisch zulaessigen saeureadditionssalze AT379594B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8024717A FR2494693A1 (fr) 1980-11-21 1980-11-21 Derives de l'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de)(naphtyridine-1,5), leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
ATA501381A ATA501381A (de) 1985-06-15
AT379594B true AT379594B (de) 1986-01-27

Family

ID=9248208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0501381A AT379594B (de) 1980-11-21 1981-11-20 Verfahren zur herstellung von neuen 2,3,3a,4,5,6hexahydro-1h-indolo(3,2,1-de)-(1,5-naphtyridin) -derivaten und ihre pharmazeutisch zulaessigen saeureadditionssalze

Country Status (22)

Country Link
JP (1) JPS57116070A (fr)
AT (1) AT379594B (fr)
AU (1) AU546924B2 (fr)
BE (1) BE891204A (fr)
CA (1) CA1162544A (fr)
CH (1) CH649549A5 (fr)
DE (1) DE3143179A1 (fr)
DK (1) DK515681A (fr)
ES (1) ES8207176A1 (fr)
FR (1) FR2494693A1 (fr)
GB (1) GB2087889B (fr)
GR (1) GR78026B (fr)
IE (1) IE52160B1 (fr)
IL (1) IL64328A (fr)
IT (1) IT1195292B (fr)
LU (1) LU83775A1 (fr)
NL (1) NL8105282A (fr)
NO (1) NO813945L (fr)
NZ (1) NZ199008A (fr)
PT (1) PT74019B (fr)
SE (1) SE8106918L (fr)
ZA (1) ZA818082B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2527210A1 (fr) * 1982-05-18 1983-11-25 Synthelabo Enantiomeres d'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de) (naphtyridine-1,5), leur procede de separation et leur application en therapeutique
JPH02180885A (ja) * 1988-09-01 1990-07-13 Glaxo Group Ltd ラクタム誘導体
CN113214250B (zh) * 2021-04-28 2022-06-14 华南理工大学 一种稠合六氢-1,6-萘啶类化合物的合成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1550496A (en) * 1976-12-31 1979-08-15 Logeais Labor Jacques 1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD129791A5 (de) * 1976-04-13 1978-02-08 Synthelabo Verfahren zur herstellung von naphtyridinderivaten

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1550496A (en) * 1976-12-31 1979-08-15 Logeais Labor Jacques 1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications

Also Published As

Publication number Publication date
NZ199008A (en) 1984-07-31
PT74019B (fr) 1983-12-07
IL64328A (en) 1985-02-28
SE8106918L (sv) 1982-05-22
ATA501381A (de) 1985-06-15
AU7770081A (en) 1982-05-27
CH649549A5 (fr) 1985-05-31
DE3143179A1 (de) 1982-06-24
JPS57116070A (en) 1982-07-19
FR2494693A1 (fr) 1982-05-28
ES507317A0 (es) 1982-09-01
FR2494693B1 (fr) 1983-03-04
NL8105282A (nl) 1982-06-16
GB2087889A (en) 1982-06-03
CA1162544A (fr) 1984-02-21
GR78026B (fr) 1984-09-26
ES8207176A1 (es) 1982-09-01
GB2087889B (en) 1984-01-25
IL64328A0 (en) 1982-02-28
IT1195292B (it) 1988-10-12
IT8125212A0 (it) 1981-11-20
AU546924B2 (en) 1985-09-26
IE812722L (en) 1982-05-21
BE891204A (fr) 1982-05-21
IE52160B1 (en) 1987-07-22
NO813945L (no) 1982-05-24
DK515681A (da) 1982-05-22
LU83775A1 (fr) 1983-09-01
ZA818082B (en) 1982-10-27
PT74019A (fr) 1981-12-01

Similar Documents

Publication Publication Date Title
AT376665B (de) Verfahren zur herstellung von neuen imidazolderivaten und von deren saeureadditionssalzen
AT381945B (de) Verfahren zur herstellung von neuen cephemverbindungen und ihren pyhsiologisch vertraeglichen saeureadditionssalzen
AT386198B (de) Verfahren zur herstellung von neuen carbostyrilderivaten und von deren pharmazeutisch annehmbaren salzen
AT382150B (de) Verfahren zur herstellung von neuen 3-amino-2-oxo-azetidin-1-sulfonsaeurederivaten
AT381705B (de) Verfahren zur herstellung von neuen thiazolidindion-derivaten und deren salzen
AT376983B (de) Verfahren zur herstellung von neuen 7-acylaminocephalosporansaeurederivaten und deren salzen
AT361481B (de) Verfahren zur herstellung von neuen 3-alkyl- -isochinolyl-5-iminothiazol(3,4-b)isochinolin- -derivaten und von deren saeureadditionssalzen
ATA149286A (de) Verfahren zur herstellung von neuen chinolinderivaten
ATA392484A (de) Verfahren zur herstellung von neuen 4,5,6,7tetrahydrothiazolo(5,4-c)pyridinderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
ATA272382A (de) Verfahren zur herstellung von neuen 3,7-diazabicyclo/3,3,1/ nonanderivaten, deren stereoisomren und physiologisch vertraeglichen saeureadditionssalzen
AT379594B (de) Verfahren zur herstellung von neuen 2,3,3a,4,5,6hexahydro-1h-indolo(3,2,1-de)-(1,5-naphtyridin) -derivaten und ihre pharmazeutisch zulaessigen saeureadditionssalze
AT379804B (de) Verfahren zur herstellung von neuen phenaethylimidazolderivaten und von deren salzen
AT374203B (de) Verfahren zur herstellung von neuen 2'-desoxy-3', 5'-di-o-alkylcarbonyl-5-fluoruridinderivaten
ATA238481A (de) Verfahren zur herstellung von neuen acylaminophenylpyridinderivaten und deren salzen
AT371469B (de) Verfahren zur herstellung von neuen penamcarbonsaeure-derivaten
ATA238683A (de) Verfahren zur herstellung von neuen eburnan-oxim-aether-derivaten und von deren saeureadditionssalzen
AT384425B (de) Verfahren zur herstellung von neuen, acylierten 1,2,4-triazolderivaten und von deren saeureadditionssalzen
ATA230583A (de) Verfahren zur herstellung von neuen saeurederivaten
AT389307B (de) Verfahren zur herstellung von neuen apovincaminolderivaten und ihren saeureadditionssalzen
AT386203B (de) Verfahren zur herstellung von neuen apovincaminol-derivaten und ihren saeureadditionssalzen
AT384806B (de) Verfahren zur herstellung von neuen 4-aryl-2-methyl-1,2,3,4-tetrahydro-isochinolinderivaten und deren salzen
AT382374B (de) Verfahren zur herstellung von neuen n-substituierten ergolin- und 9,10-didehydroergolin-8-carboxamid-derivaten
AT376419B (de) Verfahren zur herstellung von neuen n-geschuetzten 4-oxo-azetidin-2-carbonsaeurederivaten
ATA118884A (de) Verfahren zur herstellung von neuen guanin- und 2,6-diaminopurinderivaten und ihren salzen
ATA118984A (de) Verfahren zur herstellung von neuen guanin- und 2,6-diaminopurinderivaten und ihren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee